GlassScriptPhysician profile
Sean W Powers
NPI 1881222735
$3,206.25
in general payments reported to CMS, 2019-2025
16 companies · $1,766 in 2025
The $1,766 reported for 2025 was more than what 80% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,440 · 2025: $1,766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,366 · Travel and Lodging: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,366.18 |
| Travel and Lodging | $840.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,086.46 | 2024 | Intellis Adaptivestim |
| Boston Scientific Corporation | $759.06 | 2025 | Wavewriter Alpha Prime 16, Intracept, Artisan |
| Spinal Simplicity, LLC | $293.55 | 2025 | Ha Minuteman G3-R |
| Stryker Corporation | $241.19 | 2025 | Spinejack, Optablate |
| Spr Therapeutics, INC | $222.23 | 2024-2025 | Sprint Pns System |
| Globus Medical, INC. | $149.41 | 2025 | Senza |
| Nevro Corp. | $134.91 | 2024 | Senza |
| Saluda Medical Americas, INC. | $99.04 | 2024 | Evoke |
| Valinor Pharma, LLC | $42.50 | 2025 | Movantik |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.33 | 2025 | Relistor |
| Collegium Pharmaceutical, INC. | $29.96 | 2025 | Belbuca |
| Bioventus LLC | $25.28 | 2025 | Xcell |
| Scilex Pharmaceuticals INC. | $23.16 | 2025 | |
| Ani Pharmaceuticals, INC. | $22.89 | 2025 | Purified Cortrophin Gel |
| Nalu Medical, INC. | $21.58 | 2025 | Nalu Neurostimulation System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $14.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.